Antiangiogenic effect of somatostatin receptor subtype 2 on pancreatic cancer cell line: Inhibition of vascular endothelial growth factor and matrix metalloproteinase-2 expression in vitro

doi:10.3748/wjg.v10.i3.393

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 3

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2503)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-10) series.

Item

Count

PDF

259

HTML

2041

Figures (1-10)

203

Sum=2503

Feb 1, 2004 (publication date) through Nov 7, 2024

Times Cited of This Article

Times Cited (23)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Research

World J Gastroenterol. Feb 1, 2004; 10(3): 393-399
Published online Feb 1, 2004. doi: 10.3748/wjg.v10.i3.393

Full Size Figure Download Figure

Figure 4 Weak expression of VEGF mRNA in experimental group but strong expression in vector and mock control shown by RT-PCR analysis. The expected length of PCR products was 240 bp (VEGF) and 520 bp (β-actin). Lane M: DNA marker DL 2000, Lane 1: experimental group, Lane 2: vector control, Lane 3: mock control.

Citation: Kumar M, Liu ZR, Thapa L, Chang Q, Wang DY, Qin RY. Antiangiogenic effect of somatostatin receptor subtype 2 on pancreatic cancer cell line: Inhibition of vascular endothelial growth factor and matrix metalloproteinase-2 expression in vitro. World J Gastroenterol 2004; 10(3): 393-399
URL: https://www.wjgnet.com/1007-9327/full/v10/i3/393.htm
DOI: https://dx.doi.org/10.3748/wjg.v10.i3.393